Home
About
LIVE Case
Tube Movie
News
Heart Team
Terms
Home
About
LIVE Case
Tube Movie
News
Heart Team
Terms
Search
A "WARNING" SIGN IS RAISED IN LOW-RISK TAVR PATIENTS AFTER CONDUCTING META-ANALYSIS
Data from six studies indicate that whereas short-run mortality is comparable between TAVR and SAVR, a lot more of low-risk patients who have TAVR die by a couple of years.
RIVAROXABAN FOR CV EVENT REDUCTION IN CAD AND PAD PATIENTS IS ACCEPTED BY FDA
The extension changes the attention to aiming “atherothrombosis” in certain patients with chronic stable disease.
Home
About
LIVE Case
Tube Movie
News
Heart Team
Terms